Expect several messages from management on the importance of completing all your Tekturna calls this month. It’s all over folks but you won’t be told until last day of April. Good Riddance to this product. Novartis screwed this product by aiming too high on their greedy original pitch on its use with diabetics and other potential CV benefits .
Once they pulled this drug then brought it back with 3 black box warnings it was doomed. They won’t be able to save this dog of a product even with their own “superior salesforce “ either. When you have 20 other safer lower tiered antihypertensive on the market, no doctor in their right mind would use this drug very much . Tekturna is a last resort antihypertensive.( Even if my brainwashed lackey robotic DM tells me it’s a good safe drug). (NOT)
PDI is so desperate for business that they will promise anything even if they know a drug sucks . Then to make matters worse they agree to ridiculous rules with the customer like zero shared practice calls and promising to deliver unrealistic growth on a dog of a drug like Tekturna.
PDI top management does not have the guts to stand up to Novartis or any other client at negotiations and tell them zero shared practice is not acceptable or their growth projections are too high based on current market conditions and PDI’s own consultants projections.
When we re -launched Cardizem LA which was a good safe drug we had very good success. We also had 15% shared practice on the contract which helped. It was an established drug that needed some pushing because Abbott had other priorities at the time.
“ It was the right kind of contract for PDI.”
****These are the kind of contracts we should be looking for. Not dogs and other drugs with multiple black box warnings or customers with no cash*****.
**Don't blame the sales people for Tekturnas lack of growth. ***
America and company you have to be more selective to what you agree your sales team will do . Sometimes you just have to say no to fly by night small companies with no cash or tell the big companies their expectations and business rules are not realistic based on your data and knowledge of the market.
We have not had a good solid contract with a good product and 100 + calls in a long time. What’s your excuse ???? other contract companies still get them? Your new business team and contracts have sucked for the last few years at Select Access or ERT or whatever we are being called this month. Its time for a new team at the top of this group. Yea and I know and don't care if I will gone this company has been going down hill for the last several years and it is totally managements fault.
Good Luck and Good Selling to All!
Once they pulled this drug then brought it back with 3 black box warnings it was doomed. They won’t be able to save this dog of a product even with their own “superior salesforce “ either. When you have 20 other safer lower tiered antihypertensive on the market, no doctor in their right mind would use this drug very much . Tekturna is a last resort antihypertensive.( Even if my brainwashed lackey robotic DM tells me it’s a good safe drug). (NOT)
PDI is so desperate for business that they will promise anything even if they know a drug sucks . Then to make matters worse they agree to ridiculous rules with the customer like zero shared practice calls and promising to deliver unrealistic growth on a dog of a drug like Tekturna.
PDI top management does not have the guts to stand up to Novartis or any other client at negotiations and tell them zero shared practice is not acceptable or their growth projections are too high based on current market conditions and PDI’s own consultants projections.
When we re -launched Cardizem LA which was a good safe drug we had very good success. We also had 15% shared practice on the contract which helped. It was an established drug that needed some pushing because Abbott had other priorities at the time.
“ It was the right kind of contract for PDI.”
****These are the kind of contracts we should be looking for. Not dogs and other drugs with multiple black box warnings or customers with no cash*****.
**Don't blame the sales people for Tekturnas lack of growth. ***
America and company you have to be more selective to what you agree your sales team will do . Sometimes you just have to say no to fly by night small companies with no cash or tell the big companies their expectations and business rules are not realistic based on your data and knowledge of the market.
We have not had a good solid contract with a good product and 100 + calls in a long time. What’s your excuse ???? other contract companies still get them? Your new business team and contracts have sucked for the last few years at Select Access or ERT or whatever we are being called this month. Its time for a new team at the top of this group. Yea and I know and don't care if I will gone this company has been going down hill for the last several years and it is totally managements fault.
Good Luck and Good Selling to All!